Review Article
The Impact of HAART in the Gastrointestinal Tract
Erida Prifti*
Master of Science in General Medicine, Tirana, Albania
- *Corresponding Author:
- Erida Prifti
Master of Science in General Medicine, 1114
Foxwoods lane, Essex, Maryland, 21221, USA
Tel: 4439943937
E-mail: erida_prifti@live.com
Received date: October 2, 2015; Accepted date: June 10, 2016; Published date: June 16, 2016
Citation: Prifti E (2016) The Impact of HAART in the Gastrointestinal Tract. J Gastrointest Dig Syst 6:438. doi:10.4172/2161-069X.1000438
Copyright: © 2016 Prifti E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License; which permits unrestricted use; distribution; and reproduction in any medium; provided the original author and source are credited.
Abstract
Discovery of HAART announced the transformation of HIV infection from a deadly illness to a chronic manageable disease. The objective of this study is to show the impact of HAART in the GI tract. This study was conducted through online research using the database of NCBI. Multiple studies have shown that HAART has changed the clinical presentation of gastrointestinal disorders; oral lesions have decreased more than 30%; opportunistic disorders decreased from 69% to 13%. HIV patients with diarrhea receiving PI had a higher rate of response; 62% versus 33.5%. This population is at increased risk for developing malignancies of the GI tract; both proximal and distal. Even though with the introduction of HAART, patients with HIV have improved life expectancy rates and survival, public health strategies to improve cancer screening are needed.
